Scientists test 'Living Drug' to halt diabetes attack
NCT ID NCT07395050
Summary
This is a very early safety study testing a new cell therapy for people recently diagnosed with Type 1 diabetes. Researchers will collect a patient's own immune cells, modify them in a lab to target the cells that attack the pancreas, and then infuse them back. The main goal is to see if this process is safe and feasible for six adults aged 18-35 who were diagnosed within the last two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE 3 TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.